Portfolio news 0

Crescendo Limited

Crescendo Biologics and Cancer Research UK sign Clinical Development Partnership to develop CB213, a novel bispecific Humabody® therapeutic

Itaconix plc

Strong Revenue Momentum and Extended Funding

Autifony Therapeutics announces commencement of a Phase I study of AUT00201, a novel Kv3 modulator for schizophrenia and hearing disorders

Growave Ltd

Rethinking soil care in agriculture

RFC Power Ltd

Keeping ahead of the competition with IP

Xeros Technology Group plc

PrimaryBid.com Offer

Xeros Technology Group plc

Placing to raise £5.7 million PrimaryBid Offer to raise up to £0.3 million and Notice of General Meeting

Xeros Technology Group plc

Unaudited preliminary results - continued progress in 2019

Inivata Limited

Inivata Launches RaDaR™ Assay for Detection of Residual Disease and Recurrence

Intelligent Ultrasound Group plc

BodyWorks COVID-19 Ultrasound Simulator case study